Peter Molenaar

9.3k total citations
214 papers, 7.2k citations indexed

About

Peter Molenaar is a scholar working on Molecular Biology, Neurology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter Molenaar has authored 214 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Molecular Biology, 64 papers in Neurology and 60 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Molenaar's work include Receptor Mechanisms and Signaling (60 papers), Myasthenia Gravis and Thymoma (40 papers) and Ion channel regulation and function (38 papers). Peter Molenaar is often cited by papers focused on Receptor Mechanisms and Signaling (60 papers), Myasthenia Gravis and Thymoma (40 papers) and Ion channel regulation and function (38 papers). Peter Molenaar collaborates with scholars based in Australia, Netherlands and United Kingdom. Peter Molenaar's co-authors include Alberto J. Kaumann, Roger J. Summers, R. L. Polak, Jaap J. Plomp, Angela Vincent, Fraser D. Russell, Pilar Martínez‐Martínez, Mario Losen, John Newsom–Davis and Anthony P. Davenport and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Peter Molenaar

209 papers receiving 7.0k citations

Peers

Countries citing papers authored by Peter Molenaar

Since Specialization

Citations

This map shows the geographic impact of Peter Molenaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Molenaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Molenaar more than expected).

Fields of papers citing papers by Peter Molenaar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Molenaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Molenaar. The network helps show where Peter Molenaar may publish in the future.

Co-authorship network of co-authors of Peter Molenaar

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Molenaar. A scholar is included among the top collaborators of Peter Molenaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Molenaar. Peter Molenaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-GABAB receptor encephalitis: clinical and laboratory characteristics, imaging, treatments and prognosis 2024 ·Frontiers in Immunology ·(unknown), (unknown), Yaobing Yao, Peter Molenaar, Jan Damoiseaux, Huijun Li, Rob P.W. Rouhl, Pilar Martínez‐Martínez	0
2	Roles of β-adrenoceptor Subtypes and Therapeutics in Human Cardiovascular Disease: Heart Failure, Tachyarrhythmias and Other Cardiovascular Disorders 2024 ·Handbook of experimental pharmacology ·Yee Weng Wong, Haris M. Haqqani, Peter Molenaar	1
3	Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1 2023 ·Frontiers in Neurology ·(unknown), (unknown), (unknown), (unknown), Marina Mané-Damas, Peter Molenaar, Jan Damoiseaux, (unknown), Rob P.W. Rouhl, Pilar Martínez‐Martínez	3
4	Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenaline 2021 ·Pharmacology Research & Perspectives ·(unknown), (unknown), Yee Weng Wong, Haris M. Haqqani, Nicole A. Beard, Karen Hay, (unknown), (unknown), Peter Molenaar	5
5	The search for an autoimmune origin of psychotic disorders: Prevalence of autoantibodies against hippocampus antigens, glutamic acid decarboxylase and nuclear antigens 2021 ·Schizophrenia Research ·(unknown), (unknown), Marina Mané-Damas, Jo Stevens, Kishore S. Malyavantham, Cem İ̇smail Küçükali, Erdem Tüzün, Marc D. Binder, Nico J.M. van Beveren, Emiliano González‐Vioque, Celso Arango, Jan Damoiseaux, Bart P. F. Rutten, Peter Molenaar, (unknown), Pilar Martínez‐Martínez	8
6	Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4 2013 ·Autoimmunity Reviews ·Jan J.G.M. Verschuuren, Maartje G. Huijbers, Jaap J. Plomp, E. Niks, Peter Molenaar, Pilar Martínez‐Martínez, Alejandro M. Gomez, Marc H. De Baets, Mario Losen	128
7	Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis? 2012 ·Annals of the New York Academy of Sciences ·Alejandro M. Gomez, Nick Willcox, Peter Molenaar, Wim A. Buurman, Pilar Martínez‐Martínez, Marc H. De Baets, Mario Losen	34
8	Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis 2010 ·Journal of Neuroimmunology ·Kathleen Vrolix, E. Niks, Rozen Le Panse, (unknown), Anne‐Hilde Muris, (unknown), Maarten J. D. van Tol, Mario Losen, Peter Molenaar, E.J.J. van Zoelen, Sonia Berrih‐Aknin, (unknown), Jan J.G.M. Verschuuren, Pilar Martínez‐Martínez	8
9	Molecular Architecture of the Human Sinus Node 2009 ·Circulation ·Natalie Chandler, Ian D. Greener, James O. Tellez, Shin Inada, Hanny Musa, Peter Molenaar, Dario DiFrancesco, Mirko Baruscotti, Renato Longhi, Robert H. Anderson, R. Billeter, Vinod Sharma, Daniel C. Sigg, Mark R. Boyett, Halina Dobrzynski	295
10	The Effect of Plasma From Muscle-Specific Tyrosine Kinase Myasthenia Patients on Regenerating Endplates 2009 ·American Journal Of Pathology ·(unknown), Pilar Martínez‐Martínez, Mario Losen, Marc H. De Baets, Axel R. Wintzen, Jan J.G.M. Verschuuren, E. Niks, Sjoerd G. van Duinen, Angela Vincent, Peter Molenaar	32
11	P2 purinergic receptor mRNA in rat and human sinoatrial node and other heart regions 2009 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Hanny Musa, James O. Tellez, Natalie Chandler, Ian D. Greener, Michał Mączewski, Urszula Mackiewicz, A Beresewicz, Peter Molenaar, Mark R. Boyett, Halina Dobrzynski	40
12	(-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through β2-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling 2007 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Peter Molenaar, (unknown), Doreen Sarsero, Lu Chen, Annalese Semmler, (unknown), Ian A. Yang, Sabine Bartel, (unknown), (unknown), Ernst‐Georg Krause, Alberto J. Kaumann	43
13	Both 1- and 2-adrenoceptors mediate increases in contractile force and hastening of relaxation in human atrium 2004 ·Journal of Molecular and Cellular Cardiology ·(unknown), Sabine Bartel, (unknown), Peter Karczewski, Fraser D. Russell, Alberto J. Kaumann, Peter Molenaar	1
14	Studies on a novel selective beta(3)-adrenoceptor agonist in human right atrial appendage and human white adipocytes 1999 ·British Journal of Pharmacology ·(unknown), (unknown), Peter Molenaar, (unknown), (unknown), Helen Chapman, (unknown)	1
15	The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities. 1998 ·PubMed ·Matthew V. Sennitt, Alberto J. Kaumann, Peter Molenaar, Lee J. Beeley, Paul Young, John Kelly, Helen Chapman, Siân M. Henson, John M. Berge, David K. Dean, (unknown), (unknown), Harshad K. Rami, Robert W. Ward, Mervyn Thompson, Shelagh Wilson, Stephen A. Smith, Michael A. Cawthorne, Michael J. Stock, Jonathan R.S. Arch	53
16	Modulation of human cardiac function through 4 β-adrenoceptor populations 1997 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Alberto J. Kaumann, Peter Molenaar	155
17	FSCORE. A FORTRAN program for factor scores estimation in LISREL models 1996 ·UvA-DARE (University of Amsterdam) ·Peter Molenaar	2
18	Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice 1996 ·Nature Genetics ·Gert Jansen, Patricia J.T.A. Groenen, Dietmar Bächner, P. H. K. Jap, M. Coerwinkel, Frank Oerlemans, (unknown), Bärbel Gohlsch, Dirk Pette, Jaap J. Plomp, Peter Molenaar, Marcel G.J. Nederhoff, Cees J. A. van Echteld, Marleen Dekker, Anton Berns, H. Hameister, Bé Wieringa	250
19	Simultaneous genetic analysis of means and covariance structure: Pearson-Lawley selection rules 1994 ·Behavior Genetics ·Conor V. Dolan, Peter Molenaar, Dorret I. Boomsma	6
20	Neural and non-neural acetylcholine in the rat diaphragm 1982 ·Proceedings of the Royal Society of London. Series B, Biological sciences ·Ricardo Miledi, Peter Molenaar, R. L. Polak, (unknown), (unknown)	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact